## Abstract The use of genotyping assays for the detection and evaluation of drug resistance mutations within the polymerase gene of human immunodeficiency virus type 1 (HIV‐1) is becoming increasingly relevant in the clinical management of HIV‐1 infection. However, genotypic resistance assays avai
Sensitivity of the ViroSeq HIV-1 Genotyping System for Detection of the K103N Resistance Mutation in HIV-1 Subtypes A, C, and D
✍ Scribed by Church, Jessica D.; Jones, Dana; Flys, Tamara; Hoover, Donald; Marlowe, Natalia; Chen, Shu; Shi, Chanjuan; Eshleman, James R.; Guay, Laura A.; Jackson, J. Brooks; Kumwenda, Newton; Taha, Taha E.; Eshleman, Susan H.
- Book ID
- 125451668
- Publisher
- American Society for Investigative Pathology
- Year
- 2006
- Tongue
- English
- Weight
- 122 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1525-1578
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Genotypic testing for HIV‐1 resistance to anti‐retroviral drugs has become accepted widely as a routine method to guide anti‐retroviral therapy. However, implementation into routine high‐throughput laboratory diagnosis is difficult due to the complexity of the assay. A commercially avai
## Abstract The K65R mutation in HIV‐1 reverse transcriptase (RT) can be selected by the RT inhibitors tenofovir (TDF), abacavir (ABC), and didanosine (DDI). Recently, in vitro studies have shown that K65R is selected in tissue culture more rapidly with subtype C than subtype B viruses. The prevale